DIRECT SUPPRESSION OF PHAGOCYTOSIS BY AMPHIPATHIC POLYMERIC SURFACTANTS

被引:31
作者
WATROUSPELTIER, N
UHL, J
STEEL, V
BROPHY, L
MERISKOLIVERSIDGE, E
机构
[1] STERLING WINTHROP PHARMACEUT RES DIV, DEPT DRUG DELIVERY, 25 GREAT VALLEY PKWY, MALVERN, PA 19355 USA
[2] STERLING WINTHROP PHARMACEUT RES DIV, DEPT INFLAMMAT, MALVERN, PA 19355 USA
关键词
PARTICULATE CARRIERS; PHAGOCYTOSIS; SUPPRESSION; POLYMERIC SURFACTANTS;
D O I
10.1023/A:1015855906472
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Recent studies have demonstrated that phagocytosis of colloidal Particles by the mononuclear phagocytes of the liver and spleen can be controlled by either coating or stabilizing particulate carriers with the amphipathic polymeric surfactants, F108 and T908. These surfactants consist of copolymers of polypropylene oxide (PPO) and polyethylene oxide (PEO) and, when adsorbed to particulate surfaces, significantly decrease sequestration of particulates by the mononuclear phagocytes (MPS) of the liver. To evaluate these observations further, murine peritoneal macrophages were incubated for varying periods with surfactant-coated and noncoated polystyrene particles (PSPs). Phagocytosis was monitored using gamma counting and quantitative fluorescence microscopy. The data show that phagocytosis is decreased when PSPs are coated with F108 and T908. In addition, suppression of phagocytic activity was observed when cells were pretreated with the surfactant and then challenged with noncoated particles. The data confirm previous observations that polymeric surfactants consisting of PEO and PPO protect particulate carriers from rapid uptake by the MPS of the liver. Further, F108 and T908 suppress phagocytosis directly without affecting the integrity, viability, or functional state of the cell.
引用
收藏
页码:1177 / 1183
页数:7
相关论文
共 27 条
[1]  
ALVING C R, 1988, Advanced Drug Delivery Reviews, V2, P107, DOI 10.1016/0169-409X(88)90007-5
[2]   DELIVERY OF LIPOSOME-ENCAPSULATED DRUGS TO MACROPHAGES [J].
ALVING, CR .
PHARMACOLOGY & THERAPEUTICS, 1983, 22 (03) :407-424
[3]   ACRYLIC MICROSPHERES INVIVO .9. BLOOD ELIMINATION KINETICS AND ORGAN DISTRIBUTION OF MICROPARTICLES WITH DIFFERENT SURFACE CHARACTERISTICS [J].
ARTURSON, P ;
LAAKSO, T ;
EDMAN, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (12) :1415-1420
[4]  
ARTURSSON P, 1987, POLYM CONTROLLED DRU, P15
[5]  
CAWRSE N, 1990, Journal of Pharmacy and Pharmacology, V42, p153P
[6]   SYMPOSIUM ON BIOCHEMISTRY OF MACROPHAGES HELD AT THE CIBA-FOUNDATION, 16-18 APRIL 1985 - THE 1ST LINE OF DEFENSE - CHAIRMANS INTRODUCTION [J].
COHN, ZA .
CIBA FOUNDATION SYMPOSIA, 1986, 118 :1-6
[7]  
DOUGLAS SJ, 1987, CRC CRIT R THER DRUG, V3, P133
[8]   ULTRASTRUCTURAL ALTERATIONS IN MACROPHAGES AFTER PHAGOCYTOSIS OF ACRYLIC MICROSPHERES [J].
EDMAN, P ;
SJOHOLM, I ;
BRUNK, U .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (02) :153-156
[9]   THE ORGAN UPTAKE OF INTRAVENOUSLY ADMINISTERED COLLOIDAL PARTICLES CAN BE ALTERED USING A NON-IONIC SURFACTANT (POLOXAMER-338) [J].
ILLUM, L ;
DAVIS, SS .
FEBS LETTERS, 1984, 167 (01) :79-82
[10]   SURFACE CHARACTERISTICS AND THE INTERACTION OF COLLOIDAL PARTICLES WITH MOUSE PERITONEAL-MACROPHAGES [J].
ILLUM, L ;
JACOBSEN, LO ;
MULLER, RH ;
MAK, E ;
DAVIS, SS .
BIOMATERIALS, 1987, 8 (02) :113-117